Nick Paul Taylor is an experienced life sciences journalist and biopharma writer with a background in biology and healthcare innovation.

Over the past 15 years, he has covered key developments in pharmaceutical research, biotechnology, drug regulation, and medical technology, writing for leading industry publications.
Nick’s reporting focuses on translating complex clinical data, FDA updates, and biotech trends into accessible insights for professionals across the pharma and medtech sectors.

Follow Nick for expert analysis on biopharma pipelines, regulatory news, and emerging healthcare technologies.